{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-127997","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.817262+00:00","generated_at":"2026-05-29T04:05:12.842845+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Stockholders approve 1.52M share increase in 2023 Equity Incentive Plan at annual meeting","bullets":["Increase of 1,520,000 shares to 2023 Plan; total reserve now 1,651,907 shares.","Eliminated 'liberal' share recycling for stock options and SARs.","Incentive stock option limit raised to 3,619,586 shares.","David Domzalski and Patrick LePore re-elected as Class III directors.","Baker Tilly ratified as auditor; say-on-pay approved; advisory vote set for every year."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-127997","json":"https://secwatch.observer/filing/0001104659-24-127997.json","markdown":"https://secwatch.observer/filing/0001104659-24-127997.md","text":"https://secwatch.observer/filing/0001104659-24-127997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465924127997/0001104659-24-127997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465924127997/tm2430841d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:05:12.842845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}